http://waldenstroms.com/ 2018-05-17T19:22:06+00:00 1.00 http://waldenstroms.com/about-us 2018-05-17T19:22:07+00:00 0.80 http://waldenstroms.com/about-us/about-the-bing-center 2018-05-17T19:22:08+00:00 0.80 http://waldenstroms.com/about-us/bing-center-staff 2018-05-17T19:22:08+00:00 0.80 http://waldenstroms.com/about-us/directions-find-us 2018-05-17T19:22:09+00:00 0.80 http://waldenstroms.com/news 2018-05-17T19:22:10+00:00 0.80 http://waldenstroms.com/news/bing-center-news 2018-05-17T19:22:11+00:00 0.80 http://waldenstroms.com/news/newsletter-archive 2018-05-17T19:22:12+00:00 0.80 http://waldenstroms.com/news/bing-center-spotlight 2018-05-17T19:22:12+00:00 0.80 http://waldenstroms.com/events 2018-05-17T19:22:13+00:00 0.80 http://waldenstroms.com/events/event-calendar 2018-05-17T19:22:14+00:00 0.80 http://waldenstroms.com/video-photos 2018-05-17T19:22:15+00:00 0.80 http://waldenstroms.com/video-photos/media-gallery 2018-05-17T19:22:15+00:00 0.80 http://waldenstroms.com/patients-clinic 2018-05-17T19:22:16+00:00 0.80 http://waldenstroms.com/patients-clinic/bing-center-clinic 2018-05-17T19:22:17+00:00 0.80 http://waldenstroms.com/patients-clinic/clinical-trials 2018-05-17T19:22:18+00:00 0.80 http://waldenstroms.com/publications 2018-05-17T19:22:18+00:00 0.80 http://waldenstroms.com/resources 2018-05-17T19:22:19+00:00 0.80 http://waldenstroms.com/resources/related-web-links 2018-05-17T19:22:20+00:00 0.80 http://waldenstroms.com/resources/how-to-help 2018-05-17T19:22:21+00:00 0.80 http://waldenstroms.com/contact-us 2018-05-17T19:22:21+00:00 0.80 http://waldenstroms.com/news/496-dr-treon-addresses-delegates-at-emn-and-wm-patients-in-northern-italy 2018-05-17T19:22:22+00:00 0.80 http://waldenstroms.com/news/495-dr-zachary-hunter-draws-a-crowd-in-northern-va-washington-dc 2018-05-17T19:22:23+00:00 0.80 http://waldenstroms.com/news/481-us-fda-approves-new-imbruvica-ibrutinib-formulation 2018-05-17T19:22:23+00:00 0.80 http://waldenstroms.com/news/480-online-wm-workshop-progress-in-the-treatment-of-wm 2018-05-17T19:22:24+00:00 0.80 http://waldenstroms.com/news/477-5th-international-patient-and-physician-summit-on-wm 2018-05-17T19:22:25+00:00 0.80 http://waldenstroms.com/news/476-58th-annual-ash-meeting-bing-center-poster-presentations 2018-05-17T19:22:26+00:00 0.80 http://waldenstroms.com/news/475-special-presentation-on-waldenstrom-s-macroglobulinemia-feb-3-2017 2018-05-17T19:22:26+00:00 0.80 http://waldenstroms.com/news/474-what-s-new-in-the-treatment-of-waldenstrom-s-macroglobulinemia-webcast-10-4-2017 2018-05-17T19:22:27+00:00 0.80 http://waldenstroms.com/news/473-atlanta-georgia-iwmf-support-group-lecture-12-9-2017 2018-05-17T19:22:28+00:00 0.80 http://waldenstroms.com/news/472-iwmf-new-england-support-group-meeting-12-3-2017 2018-05-17T19:22:29+00:00 0.80 http://waldenstroms.com/news/bing-center-spotlight/479-ash-2017-bing-center-poster-presentations 2018-05-17T19:22:30+00:00 0.80 http://waldenstroms.com/images/news/ASH-2017/12-11-2017-PUB3812.pdf 2018-05-09T19:04:43+00:00 0.80 http://waldenstroms.com/23-researchers-physicians/10-basic-research 2018-05-17T19:22:34+00:00 0.80 http://waldenstroms.com/23-researchers-physicians/417-genomics-signaling-and-treatment-of-waldenstroem-s-macroglobulinemia 2018-05-17T19:22:35+00:00 0.80 http://waldenstroms.com/16-legal/19-legal-statements 2018-05-17T19:22:36+00:00 0.80 http://waldenstroms.com/16-legal/18-privacy-policy 2018-05-17T19:22:36+00:00 0.80 http://waldenstroms.com/about-us/bing-center-staff/478-cristina-jimenez-ph-d 2018-05-17T19:22:37+00:00 0.64 http://waldenstroms.com/about-us/bing-center-staff/460-manit-munshi 2018-05-17T19:22:38+00:00 0.64 http://waldenstroms.com/about-us/bing-center-staff/454-siobhan-lamont 2018-05-17T19:22:38+00:00 0.64 http://waldenstroms.com/about-us/bing-center-staff/414-megan-ryan 2018-05-17T19:22:39+00:00 0.64 http://waldenstroms.com/about-us/bing-center-staff/411-amanda-kofides 2018-05-17T19:22:40+00:00 0.64 http://waldenstroms.com/about-us/bing-center-staff/408-gloria-chan 2018-05-17T19:22:40+00:00 0.64 http://waldenstroms.com/about-us/bing-center-staff/389-maria-demos 2018-05-17T19:22:41+00:00 0.64 http://waldenstroms.com/about-us/bing-center-staff/383-toni-dubeau-rn-np 2018-05-17T19:22:42+00:00 0.64 http://waldenstroms.com/about-us/bing-center-staff/378-jiaji-chen 2018-05-17T19:22:42+00:00 0.64 http://waldenstroms.com/about-us/bing-center-staff/373-josh-gustine 2018-05-17T19:22:43+00:00 0.64 http://waldenstroms.com/about-us/bing-center-staff/212-zachary-hunter-ph-d 2018-05-17T19:22:44+00:00 0.64 http://waldenstroms.com/about-us/bing-center-staff/211-xia-liu-md 2018-05-17T19:22:44+00:00 0.64 http://waldenstroms.com/about-us/bing-center-staff/210-steven-p-treon-md-ph-d 2018-05-17T19:22:45+00:00 0.64 http://waldenstroms.com/about-us/bing-center-staff/208-robert-manning-fm-rng 2018-05-17T19:22:46+00:00 0.64 http://waldenstroms.com/about-us/bing-center-staff/207-phil-brodsky 2018-05-17T19:22:46+00:00 0.64 http://waldenstroms.com/about-us/bing-center-staff/206-nick-tsakmaklis 2018-05-17T19:22:47+00:00 0.64 http://waldenstroms.com/about-us/bing-center-staff/205-lian-xu 2018-05-17T19:22:48+00:00 0.64 http://waldenstroms.com/about-us/bing-center-staff/204-kirsten-meid 2018-05-17T19:22:48+00:00 0.64 http://waldenstroms.com/about-us/bing-center-staff/203-jorge-j-castillo-md 2018-05-17T19:22:49+00:00 0.64 http://waldenstroms.com/about-us/bing-center-staff/200-guang-yang-md 2018-05-17T19:22:50+00:00 0.64 http://waldenstroms.com/about-us/bing-center-staff?start=20 2018-05-17T19:22:50+00:00 0.64 http://waldenstroms.com/news/471-professor-treon-invited-to-speak-at-the-jsh-meeting-in-tokyo-japan-on-waldenstrom-s-macroglobulinemia 2018-05-17T19:22:51+00:00 0.64 http://waldenstroms.com/news/470-masterclass-on-waldenstrom-s-macroglobulinemia-for-hematology-doctors-in-training-in-ireland 2018-05-17T19:22:52+00:00 0.64 http://waldenstroms.com/news/467-colorado-so-wyoming-support-group-meeting-oct-14-2017 2018-05-17T19:22:52+00:00 0.64 http://waldenstroms.com/news/466-la-orange-county-support-group-meeting-nov-19-2017 2018-05-17T19:22:53+00:00 0.64 http://waldenstroms.com/news/465-san-diego-support-group-meeting-nov-18-2017 2018-05-17T19:22:53+00:00 0.64 http://waldenstroms.com/news/462-fall-meetings-for-the-eastern-mass-southern-nh-iwmf-support-group 2018-05-17T19:22:54+00:00 0.64 http://waldenstroms.com/news/461-iwmf-publications-including-the-new-faq-guide 2018-05-17T19:22:55+00:00 0.64 http://waldenstroms.com/news/459-register-for-the-free-cancercare-workshop-on-wm 2018-05-17T19:22:55+00:00 0.64 http://waldenstroms.com/news/457-rocky-mtn-support-group-oct-14-2017 2018-05-17T19:22:56+00:00 0.64 http://waldenstroms.com/news/456-heavy-attendance-at-the-session-on-waldenstrom-s-macroglobulinemia-at-the-22nd-european-hematology-association-meeting-madrid-spain 2018-05-17T19:22:57+00:00 0.64 http://waldenstroms.com/news?start=20 2018-05-17T19:22:57+00:00 0.64 http://waldenstroms.com/news?start=40 2018-05-17T19:22:58+00:00 0.64 http://waldenstroms.com/news?start=60 2018-05-17T19:22:59+00:00 0.64 http://waldenstroms.com/news?start=80 2018-05-17T19:22:59+00:00 0.64 http://waldenstroms.com/news?start=100 2018-05-17T19:23:00+00:00 0.64 http://waldenstroms.com/news/bing-center-news?start=20 2018-05-17T19:23:01+00:00 0.64 http://waldenstroms.com/news/bing-center-news?start=40 2018-05-17T19:23:01+00:00 0.64 http://waldenstroms.com/news/bing-center-news?start=60 2018-05-17T19:23:02+00:00 0.64 http://waldenstroms.com/news/bing-center-news?start=80 2018-05-17T19:23:03+00:00 0.64 http://waldenstroms.com/news/bing-center-news?start=100 2018-05-17T19:23:03+00:00 0.64 http://waldenstroms.com/news/newsletter-archive/275-march-2015 2018-05-17T19:23:04+00:00 0.64 http://waldenstroms.com/news/newsletter-archive/274-october-2014 2018-05-17T19:23:05+00:00 0.64 http://waldenstroms.com/news/newsletter-archive/273-january-2013 2018-05-17T19:23:05+00:00 0.64 http://waldenstroms.com/news/newsletter-archive/272-february-2012 2018-05-17T19:23:06+00:00 0.64 http://waldenstroms.com/news/newsletter-archive/271-november-2011 2018-05-17T19:23:07+00:00 0.64 http://waldenstroms.com/news/newsletter-archive/270-september-2011 2018-05-17T19:23:07+00:00 0.64 http://waldenstroms.com/news/newsletter-archive/269-february-2011 2018-05-17T19:23:08+00:00 0.64 http://waldenstroms.com/news/newsletter-archive/268-november-2010 2018-05-17T19:23:09+00:00 0.64 http://waldenstroms.com/news/newsletter-archive/267-september-2010 2018-05-17T19:23:09+00:00 0.64 http://waldenstroms.com/news/newsletter-archive/266-june-2010 2018-05-17T19:23:10+00:00 0.64 http://waldenstroms.com/news/newsletter-archive/265-april-2010 2018-05-17T19:23:11+00:00 0.64 http://waldenstroms.com/news/newsletter-archive/264-january-2010 2018-05-17T19:23:11+00:00 0.64 http://waldenstroms.com/news/newsletter-archive/263-november-2009 2018-05-17T19:23:12+00:00 0.64 http://waldenstroms.com/news/newsletter-archive/262-september-2009 2018-05-17T19:23:13+00:00 0.64 http://waldenstroms.com/news/newsletter-archive/261-july-2009 2018-05-17T19:23:13+00:00 0.64 http://waldenstroms.com/news/newsletter-archive/260-april-2009 2018-05-17T19:23:14+00:00 0.64 http://waldenstroms.com/news/newsletter-archive/259-january-2009 2018-05-17T19:23:15+00:00 0.64 http://waldenstroms.com/news/bing-center-spotlight/469-dr-jorge-castillo-captivates-waldenstr-m-audience-in-new-york-city 2018-05-17T19:23:15+00:00 0.64 http://waldenstroms.com/news/bing-center-spotlight/427-dana-farber-honors-bing-center-scientist-and-innovator 2018-05-17T19:23:16+00:00 0.64 http://waldenstroms.com/news/bing-center-spotlight/416-dr-treon-promoted-to-full-professor 2018-05-17T19:23:17+00:00 0.64 http://waldenstroms.com/news/bing-center-spotlight/380-ed-and-marian-saltzman 2018-05-17T19:23:17+00:00 0.64 http://waldenstroms.com/news/bing-center-spotlight/7-new-waldenstrom-s-drug-shows-sustained-benefit-after-2-years 2018-05-17T19:23:18+00:00 0.64 http://waldenstroms.com/news/bing-center-spotlight/281-survival-trends-in-wm 2018-05-17T19:23:19+00:00 0.64 http://waldenstroms.com/news/bing-center-spotlight/280-bing-center-discovers-highly-prevalent-mutations-in-the-cxcr4-gene-in-patients-with-waldenstrom-s-macroglobulinemia 2018-05-17T19:23:19+00:00 0.64 http://waldenstroms.com/news/bing-center-spotlight/279-welcome-sandra-kanan-and-jorge-castillo 2018-05-17T19:23:20+00:00 0.64 http://waldenstroms.com/news/bing-center-spotlight/278-myd88-l265p-somatic-mutation-in-wm 2018-05-17T19:23:21+00:00 0.64 http://waldenstroms.com/news/bing-center-spotlight/277-human-genome-faqs 2018-05-17T19:23:22+00:00 0.64 http://waldenstroms.com/news/bing-center-spotlight/276-advances-in-genetics-and-treatment-of-waldenstrom-s-macroglobulinemia 2018-05-17T19:23:22+00:00 0.64 http://waldenstroms.com/events/332-upcoming-events 2018-05-17T19:23:23+00:00 0.64 http://waldenstroms.com/video-photos/367-genomic-advances-in-the-treatment-of-wm-2 2018-05-17T19:23:24+00:00 0.64 http://waldenstroms.com/video-photos/366-12th-international-conference-on-malignant-lymphoma-12-icml-2 2018-05-17T19:23:24+00:00 0.64 http://waldenstroms.com/video-photos/365-3rd-international-patient-forum-on-wm 2018-05-17T19:23:25+00:00 0.64 http://waldenstroms.com/video-photos/364-new-england-support-group-meeting 2018-05-17T19:23:26+00:00 0.64 http://waldenstroms.com/video-photos/363-iwmf-patient-ed-forum-june-24-26-2011-ask-the-doctor-panel-discussion 2018-05-17T19:23:26+00:00 0.64 http://waldenstroms.com/video-photos/362-advances-in-genetics-and-treatment-of-waldenstrom-s-macroglobulinemia 2018-05-17T19:23:27+00:00 0.64 http://waldenstroms.com/video-photos/361-massachusetts-lrf-workshop 2018-05-17T19:23:27+00:00 0.64 http://waldenstroms.com/video-photos/360-genetics-of-familial-wm-orlando-patient-physician-summit-march-2011-zachary-hunter 2018-05-17T19:23:28+00:00 0.64 http://waldenstroms.com/video-photos/359-twelve-weeks-orlando-patient-physician-summit-march-2011-karen-lee-sobol 2018-05-17T19:23:29+00:00 0.64 http://waldenstroms.com/video-photos/358-maintenance-rituximab-in-wm-orlando-patient-physician-summit-march-2011-leukothea-ioakimidis 2018-05-17T19:23:29+00:00 0.64 http://waldenstroms.com/video-photos?start=10 2018-05-17T19:23:30+00:00 0.64 http://waldenstroms.com/video-photos?start=20 2018-05-17T19:23:31+00:00 0.64 http://waldenstroms.com/video-photos?start=30 2018-05-17T19:23:31+00:00 0.64 http://waldenstroms.com/video-photos/media-gallery?start=10 2018-05-17T19:23:32+00:00 0.64 http://waldenstroms.com/video-photos/media-gallery?start=20 2018-05-17T19:23:33+00:00 0.64 http://waldenstroms.com/video-photos/media-gallery?start=30 2018-05-17T19:23:34+00:00 0.64 http://waldenstroms.com/images/clinic/authtoreleasephi.pdf 2018-05-09T19:04:48+00:00 0.64 http://waldenstroms.com/patients-clinic/clinical-trials/43-current-trials 2018-05-17T19:23:35+00:00 0.64 http://waldenstroms.com/patients-clinic/clinical-trials/44-corollary-studies 2018-05-17T19:23:36+00:00 0.64 http://waldenstroms.com/patients-clinic/clinical-trials/45-completed-trials 2018-05-17T19:23:36+00:00 0.64 http://waldenstroms.com/patients-clinic/clinical-trials/46-participating-institutions-usa 2018-05-17T19:23:37+00:00 0.64 http://waldenstroms.com/patients-clinic/clinical-trials/47-participating-institutions-international 2018-05-17T19:23:38+00:00 0.64 http://waldenstroms.com/publications/26-pub-2015/370-how-i-treat-waldenstrom-macroglobulinemia 2018-05-17T19:23:38+00:00 0.64 http://waldenstroms.com/publications/26-pub-2015/368-ibrutinib-in-previously-treated-waldenstrom-s-macroglobulinemia 2018-05-17T19:23:39+00:00 0.64 http://waldenstroms.com/publications/26-pub-2015/371-biology-prognosis-and-therapy-of-waldenstroem-macroglobulinemia 2018-05-17T19:23:40+00:00 0.64 http://waldenstroms.com/publications/26-pub-2015/369-survival-outcomes-of-secondary-cancers-in-patients-with-waldenstroem-macroglobulinemia-an-analysis-of-the-seer-database 2018-05-17T19:23:40+00:00 0.64 http://waldenstroms.com/publications/51-pub-2018 2018-05-17T19:23:41+00:00 0.64 http://waldenstroms.com/publications/50-pub-2017 2018-05-17T19:23:42+00:00 0.64 http://waldenstroms.com/publications/49-pub-2016 2018-05-17T19:23:42+00:00 0.64 http://waldenstroms.com/publications/26-pub-2015 2018-05-17T19:23:43+00:00 0.64 http://waldenstroms.com/publications/27-pub-2014 2018-05-17T19:23:44+00:00 0.64 http://waldenstroms.com/publications/28-pub-2013 2018-05-17T19:23:44+00:00 0.64 http://waldenstroms.com/publications/29-pub-2012 2018-05-17T19:23:45+00:00 0.64 http://waldenstroms.com/publications/30-pub-2011 2018-05-17T19:23:46+00:00 0.64 http://waldenstroms.com/publications/31-pub-2010 2018-05-17T19:23:46+00:00 0.64 http://waldenstroms.com/publications/32-pub-2009 2018-05-17T19:23:47+00:00 0.64 http://waldenstroms.com/publications/33-pub-2008 2018-05-17T19:23:48+00:00 0.64 http://waldenstroms.com/publications/34-pub-2007 2018-05-17T19:23:48+00:00 0.64 http://waldenstroms.com/publications/35-pub-2006 2018-05-17T19:23:49+00:00 0.64 http://waldenstroms.com/publications/36-pub-2005 2018-05-17T19:23:50+00:00 0.64 http://waldenstroms.com/publications/37-pub-2004 2018-05-17T19:23:50+00:00 0.64 http://waldenstroms.com/publications/38-pub-2003 2018-05-17T19:23:51+00:00 0.64 http://waldenstroms.com/publications/39-pub-2001-2002 2018-05-17T19:23:52+00:00 0.64 http://waldenstroms.com/publications/40-pub-1999-2000 2018-05-17T19:23:52+00:00 0.64 http://waldenstroms.com/publications/41-pub-1997-1998 2018-05-17T19:23:53+00:00 0.64 http://waldenstroms.com/publications/42-pub-1992-1996 2018-05-17T19:23:54+00:00 0.64 http://waldenstroms.com/publications/30-pub-2011/69-how-i-treat-the-acquired-von-willebrand-syndrome 2018-05-17T19:23:54+00:00 0.64 http://waldenstroms.com/resources?start=20 2018-05-17T19:23:55+00:00 0.64 http://waldenstroms.com/resources/related-web-links?start=20 2018-05-17T19:23:56+00:00 0.64 http://waldenstroms.com/resources/how-to-help/331-wm-research-fund 2018-05-17T19:23:56+00:00 0.64 http://waldenstroms.com/resources/how-to-help/330-wm-educational-fund 2018-05-17T19:23:57+00:00 0.64 http://waldenstroms.com/resources/how-to-help/329-the-research-fund-for-waldenstrom-s-at-dana-farber 2018-05-17T19:23:58+00:00 0.64 http://waldenstroms.com/resources/how-to-help/328-peter-and-helen-bing-fund 2018-05-17T19:23:58+00:00 0.64 http://waldenstroms.com/resources/how-to-help/327-general-donations-fund 2018-05-17T19:23:59+00:00 0.64 http://waldenstroms.com/resources/how-to-help/326-bailey-family-fund 2018-05-17T19:24:00+00:00 0.64 http://waldenstroms.com/images/news/ASH-2017/12-09-2017-PUB1088.pdf 2018-05-09T19:04:43+00:00 0.64 http://waldenstroms.com/images/news/ASH-2017/12-09-2017-PUB1199.pdf 2018-05-09T19:04:42+00:00 0.64 http://waldenstroms.com/images/news/ASH-2017/12-09-2017-PUB1462.pdf 2018-05-09T19:04:43+00:00 0.64 http://waldenstroms.com/images/news/ASH-2017/12-09-2017-PUB1487.pdf 2018-05-09T19:04:43+00:00 0.64 http://waldenstroms.com/images/news/ASH-2017/12-09-2017-PUB1488.pdf 2018-05-09T19:04:43+00:00 0.64 http://waldenstroms.com/images/news/ASH-2017/12-10-2017-PUB2539.pdf 2018-05-09T19:04:43+00:00 0.64 http://waldenstroms.com/images/news/ASH-2017/12-10-2017-PUB2766.pdf 2018-05-09T19:04:43+00:00 0.64 http://waldenstroms.com/images/news/ASH-2017/12-10-2017-PUB2767.pdf 2018-05-09T19:04:43+00:00 0.64 http://waldenstroms.com/images/news/ASH-2017/12-10-2017-PUB2772.pdf 2018-05-09T19:04:43+00:00 0.64 http://waldenstroms.com/images/news/ASH-2017/12-11-2017-PUB4006.pdf 2018-05-09T19:04:43+00:00 0.64 http://waldenstroms.com/images/news/ASH-2017/12-11-2017-PUB4011.pdf 2018-05-09T19:04:42+00:00 0.64 http://waldenstroms.com/images/news/ASH-2017/12-11-2017-PUB4043.pdf 2018-05-09T19:04:43+00:00 0.64 http://waldenstroms.com/images/news/ASH-2017/12-11-2017-PUB4051.pdf 2018-05-09T19:04:43+00:00 0.64 http://waldenstroms.com/images/news/ASH-2017/12-11-2017-PUB4058.pdf 2018-05-09T19:04:42+00:00 0.64 http://waldenstroms.com/images/news/ASH-2017/12-11-2017-PUB4385.pdf 2018-05-09T19:04:43+00:00 0.64 http://waldenstroms.com/images/news/SarasotaMeetingFeb032017.pdf 2018-05-09T19:04:41+00:00 0.64 http://waldenstroms.com/images/news/ATLSGM-120917.pdf 2018-05-09T19:04:40+00:00 0.64 http://waldenstroms.com/images/news/NESGM-Dec2017.pdf 2018-05-09T19:04:39+00:00 0.64 http://waldenstroms.com/23-researchers-physicians 2018-05-17T19:24:38+00:00 0.64 http://waldenstroms.com/16-legal 2018-05-17T19:24:38+00:00 0.64 http://waldenstroms.com/about-us/bing-center-staff/198-christopher-patterson 2018-05-17T19:24:39+00:00 0.51 http://waldenstroms.com/about-us/bing-center-staff?limitstart=0 2018-05-17T19:24:40+00:00 0.51 http://waldenstroms.com/images/news/DuarteCA-SGM.pdf 2018-05-09T19:04:41+00:00 0.51 http://waldenstroms.com/images/news/SanDiegoCA-SGM.pdf 2018-05-09T19:04:39+00:00 0.51 http://waldenstroms.com/images/news/DFCIDirections.pdf 2018-05-09T19:04:39+00:00 0.51 http://waldenstroms.com/images/news/DFCIParking.pdf 2018-05-09T19:04:39+00:00 0.51 http://waldenstroms.com/images/news/IWMF/2017-CO-SGM.pdf 2018-05-09T19:04:42+00:00 0.51 http://waldenstroms.com/news/455-bing-center-lectures-video-from-iwmf-2017-ed-forum-phoenix-az-may-19-21-2017 2018-05-17T19:24:45+00:00 0.51 http://waldenstroms.com/news/453-2017-ed-forum-phoenix-az-may-19-21 2018-05-17T19:24:46+00:00 0.51 http://waldenstroms.com/news/452-dallas-tx-support-group-meeting-june-17-2017 2018-05-17T19:24:47+00:00 0.51 http://waldenstroms.com/news/451-waldenstrom-s-macroglobulinemia-1st-ed-2017 2018-05-17T19:24:47+00:00 0.51 http://waldenstroms.com/news/450-new-england-support-group-meeting-june-4-2017 2018-05-17T19:24:48+00:00 0.51 http://waldenstroms.com/news/449-dallas-support-group-meeting-june-10-2017 2018-05-17T19:24:49+00:00 0.51 http://waldenstroms.com/news/426-a-note-of-thanks-from-the-support-group-meeting-in-va-dc-4-1-2017 2018-05-17T19:24:49+00:00 0.51 http://waldenstroms.com/news/425-nccn-2017-guidelines-for-wm-patients 2018-05-17T19:24:50+00:00 0.51 http://waldenstroms.com/news/424-new-york-metro-support-group-meeting-april-23-2017 2018-05-17T19:24:50+00:00 0.51 http://waldenstroms.com/news/423-chicago-area-support-group-meeting-june-10-2017 2018-05-17T19:24:51+00:00 0.51 http://waldenstroms.com/news/422-eastern-ma-iwmf-support-group-winter-meeting 2018-05-17T19:24:51+00:00 0.51 http://waldenstroms.com/news/421-n-va-wash-dc-w-maryland-support-group-meeting 2018-05-17T19:24:52+00:00 0.51 http://waldenstroms.com/news/420-cancercare-webcast-advances-in-the-treatment-of-wm-now-available-online 2018-05-17T19:24:53+00:00 0.51 http://waldenstroms.com/news/419-lls-2017-blood-cancer-conference 2018-05-17T19:24:53+00:00 0.51 http://waldenstroms.com/news/418-imbruvica-approved-in-2017-israeli-healthcare-basket 2018-05-17T19:24:54+00:00 0.51 http://waldenstroms.com/news/413-ash-2016-meeting-exposition 2018-05-17T19:24:54+00:00 0.51 http://waldenstroms.com/news/412-amsterdam-2016-doctor-patient-forum-presentations 2018-05-17T19:24:55+00:00 0.51 http://waldenstroms.com/news/410-amsterdam-2016-iwwm-9-bing-center-presentations 2018-05-17T19:24:56+00:00 0.51 http://waldenstroms.com/news/409-amsterdam-2016-iwwm-9-poster-presentations 2018-05-17T19:24:56+00:00 0.51 http://waldenstroms.com/news/407-dr-castillo-presentation-to-wash-dc-area-iwmf-support-group 2018-05-17T19:25:01+00:00 0.51 http://waldenstroms.com/news?limitstart=0 2018-05-17T19:25:02+00:00 0.51 http://waldenstroms.com/news/405-translating-genomic-advances-into-novel-therapies-for-wm-video-now-available 2018-05-17T19:25:03+00:00 0.51 http://waldenstroms.com/news/404-frontline-treatment-options-side-effects-video-now-available 2018-05-17T19:25:03+00:00 0.51 http://waldenstroms.com/news/403-upfront-therapy-for-lymphoplasmacytic-lymphoma-waldenstrom-s-macroglobulinemia 2018-05-17T19:25:04+00:00 0.51 http://waldenstroms.com/news/399-2016-iwmf-educational-forum 2018-05-17T19:25:04+00:00 0.51 http://waldenstroms.com/news/391-iwmf-support-group-meeting-3-6-2016 2018-05-17T19:25:05+00:00 0.51 http://waldenstroms.com/news/390-welcome-maria-luisa-guerrera 2018-05-17T19:25:06+00:00 0.51 http://waldenstroms.com/news/388-ash-2015-meeting-exposition 2018-05-17T19:25:07+00:00 0.51 http://waldenstroms.com/news/387-lymphoma-research-foundation-webcasts 2018-05-17T19:25:07+00:00 0.51 http://waldenstroms.com/news/386-spanish-hematology-congress-valencia-spain 2018-05-17T19:25:08+00:00 0.51 http://waldenstroms.com/news/385-should-patients-pay-to-play 2018-05-17T19:25:09+00:00 0.51 http://waldenstroms.com/news/379-running-for-dana-farber-dr-edward-laane 2018-05-17T19:25:09+00:00 0.51 http://waldenstroms.com/news/375-meet-josephine-vos-md 2018-05-17T19:25:10+00:00 0.51 http://waldenstroms.com/news/372-european-medicines-agency-issues-positive-opinion-recommends-full-approval-of-imbruvica-ibrutinib-to-treat-waldenstrom-s-macroglobulinemia 2018-05-17T19:25:10+00:00 0.51 http://waldenstroms.com/news/17-running-for-waldenstrom-s-part-2 2018-05-17T19:25:11+00:00 0.51 http://waldenstroms.com/news/16-2015-iwmf-educational-forum 2018-05-17T19:25:12+00:00 0.51 http://waldenstroms.com/news/15-what-it-s-like-to-enroll-in-a-clinical-trial 2018-05-17T19:25:13+00:00 0.51 http://waldenstroms.com/news/14-2014-ash-exposition-and-conference 2018-05-17T19:25:13+00:00 0.51 http://waldenstroms.com/news/13-running-for-waldenstrom-s-sandra-kanan 2018-05-17T19:25:14+00:00 0.51 http://waldenstroms.com/news/12-pharmacyclics-files-supplemental-new-drug-application-for-imbruvica-for-waldenstrom-s-macroglobulinemia 2018-05-17T19:25:15+00:00 0.51 http://waldenstroms.com/news/8-u-s-fda-approves-imbruvica-ibrutinib-for-treatment-of-waldenstrom-s-macroglobulinemia 2018-05-17T19:25:15+00:00 0.51 http://waldenstroms.com/news/257-8th-international-workshop-on-wm-2 2018-05-17T19:25:16+00:00 0.51 http://waldenstroms.com/news/256-clinical-study-for-carfilzomib-dexamethasone-and-rituximab-card-reported-in-blood 2018-05-17T19:25:17+00:00 0.51 http://waldenstroms.com/news/255-dr-treon-presents-findings-from-the-whole-genome-sequencing-project-at-the-annual-meeting-of-the-international-waldenstrom-s-macroglobulinemia-foundation-in-tampa-fl 2018-05-17T19:25:17+00:00 0.51 http://waldenstroms.com/news/254-study-by-the-bing-center-shows-improving-survival-trends-for-wm 2018-05-17T19:25:18+00:00 0.51 http://waldenstroms.com/news/253-zachary-hunter-and-steve-treon-deliver-addresses-at-the-iwmf-canada-annual-meeting-in-vancouver-bc 2018-05-17T19:25:19+00:00 0.51 http://waldenstroms.com/news/252-dr-treon-addresses-the-clinical-advisory-committee-of-the-world-health-organization-who-in-chicago-il 2018-05-17T19:25:19+00:00 0.51 http://waldenstroms.com/news/251-national-comprehensive-cancer-network-nccn-adds-ibrutinib-to-the-list-of-therapies-for-wm-patients-with-relapsed-or-refractory-wm 2018-05-17T19:25:20+00:00 0.51 http://waldenstroms.com/news/250-ash-2013-attendees 2018-05-17T19:25:21+00:00 0.51 http://waldenstroms.com/news/249-ash-2013-annual-meeting-and-exposition 2018-05-17T19:25:21+00:00 0.51 http://waldenstroms.com/news/248-bing-center-hosts-dutch-delegation 2018-05-17T19:25:22+00:00 0.51 http://waldenstroms.com/news/247-dr-treon-lecture-to-polish-physician-s-committee 2018-05-17T19:25:23+00:00 0.51 http://waldenstroms.com/news/246-karen-lee-sobol-throws-out-1st-pitch 2018-05-17T19:25:23+00:00 0.51 http://waldenstroms.com/news/245-dr-treon-lecture-to-new-england-support-group 2018-05-17T19:25:24+00:00 0.51 http://waldenstroms.com/news/244-ibrutinib-receives-fda-breakthrough-therapy-status 2018-05-17T19:25:25+00:00 0.51 http://waldenstroms.com/news/243-wm-national-community 2018-05-17T19:25:25+00:00 0.51 http://waldenstroms.com/news/242-7th-international-workshop-on-wm 2018-05-17T19:25:26+00:00 0.51 http://waldenstroms.com/news/241-asco-2012-annual-meeting-and-exposition 2018-05-17T19:25:26+00:00 0.51 http://waldenstroms.com/news/240-ash-2011-annual-meeting 2018-05-17T19:25:27+00:00 0.51 http://waldenstroms.com/news/239-walkin-for-waldenstrom-s 2018-05-17T19:25:28+00:00 0.51 http://waldenstroms.com/news/238-4th-international-patient-physician-summit 2018-05-17T19:25:28+00:00 0.51 http://waldenstroms.com/news/237-ash-2010-poster-presentations 2018-05-17T19:25:29+00:00 0.51 http://waldenstroms.com/news/236-6th-international-workshop-on-wm 2018-05-17T19:25:30+00:00 0.51 http://waldenstroms.com/news/235-dr-treon-s-visit-to-walter-reed-army-medical-center 2018-05-17T19:25:31+00:00 0.51 http://waldenstroms.com/news/234-asco-2010-poster-presentations 2018-05-17T19:25:31+00:00 0.51 http://waldenstroms.com/news/233-recent-and-upcoming-support-group-meetings 2018-05-17T19:25:32+00:00 0.51 http://waldenstroms.com/news/232-florida-support-group-meetings 2018-05-17T19:25:33+00:00 0.51 http://waldenstroms.com/news/231-ash-2009-december-5-8-new-orleans-la 2018-05-17T19:25:33+00:00 0.51 http://waldenstroms.com/news/230-dr-robert-kyle-bing-center-visit 2018-05-17T19:25:34+00:00 0.51 http://waldenstroms.com/news/229-canadian-patient-physician-conference-toronto-canada 2018-05-17T19:25:34+00:00 0.51 http://waldenstroms.com/news/228-the-third-international-patient-and-physician-summit-on-waldenstrom-s-macroglobulinemia-and-10th-anniversary-gala-of-the-bing-center-for-wm 2018-05-17T19:25:35+00:00 0.51 http://waldenstroms.com/news/227-lian-xu-s-5-year-anniversary-with-the-bing-center-for-wm 2018-05-17T19:25:36+00:00 0.51 http://waldenstroms.com/news/226-american-society-of-clinical-oncology 2018-05-17T19:25:36+00:00 0.51 http://waldenstroms.com/news/225-support-group-meetings-dallas-houston-texas 2018-05-17T19:25:37+00:00 0.51 http://waldenstroms.com/news/224-support-group-meeting-sarasota-florida 2018-05-17T19:25:38+00:00 0.51 http://waldenstroms.com/news/223-support-group-meeting-san-francisco-ca 2018-05-17T19:25:39+00:00 0.51 http://waldenstroms.com/news/222-wm-familial-genetics-study-is-now-open 2018-05-17T19:25:39+00:00 0.51 http://waldenstroms.com/news/221-american-society-of-hematology-orlando-fl 2018-05-17T19:25:40+00:00 0.51 http://waldenstroms.com/news/220-north-american-educational-forum-on-lymphoma-ed-forum 2018-05-17T19:25:41+00:00 0.51 http://waldenstroms.com/news/219-support-group-meeting-park-ridge-il-representing-illinois-michigan-wisconsin 2018-05-17T19:25:41+00:00 0.51 http://waldenstroms.com/news/218-update-on-treatment-recommendations-from-third-international-wm-workshop-to-be-published 2018-05-17T19:25:42+00:00 0.51 http://waldenstroms.com/news/217-10th-international-myeloma-workshop-strengthens-ties-between-myeloma-and-wm 2018-05-17T19:25:43+00:00 0.51 http://waldenstroms.com/news/216-ben-rude-1931-2005 2018-05-17T19:25:43+00:00 0.51 http://waldenstroms.com/news/215-robert-manning-receives-the-sidney-farber-volunteer-award 2018-05-17T19:25:44+00:00 0.51 http://waldenstroms.com/news/214-asco-hosts-first-ever-meet-the-professor-session-on-waldenstrom-s-macroglobulinemia 2018-05-17T19:25:45+00:00 0.51 http://waldenstroms.com/news/bing-center-news?limitstart=0 2018-05-17T19:25:45+00:00 0.51 http://waldenstroms.com/images/Lugano-2013/Default.html 2018-05-09T19:04:37+00:00 0.51 http://waldenstroms.com/video-photos/357-frontline-therapy-of-wm-orlando-patient-physician-summit-march-2011-steven-treon-md-ph-d 2018-05-17T19:25:50+00:00 0.51 http://waldenstroms.com/video-photos/356-gep-and-microrna-profiling-orlando-patient-physician-summit-march-2011-zachary-hunter 2018-05-17T19:25:51+00:00 0.51 http://waldenstroms.com/video-photos/355-peripheral-neuropathy-in-wm-orlando-patient-physician-summit-march-2011-tricia-sheehy-np 2018-05-17T19:25:51+00:00 0.51 http://waldenstroms.com/video-photos/354-bortezomib-velcade-based-therapy-in-wm-boston-patient-physician-summit-may-2009-steven-treon-md-ph-d 2018-05-17T19:25:52+00:00 0.51 http://waldenstroms.com/video-photos/353-comparative-outcomes-following-cp-r-cvp-r-and-chop-r-in-wm-boston-patient-physician-summit-may-2009-thea-ioakimidis 2018-05-17T19:25:53+00:00 0.51 http://waldenstroms.com/video-photos/352-demethylation-therapy-in-wm-boston-patient-physician-summit-may-2009-lian-xu 2018-05-17T19:25:53+00:00 0.51 http://waldenstroms.com/video-photos/351-mast-cells-and-scd27-in-wm-boston-2009-patient-physician-summit-may-2009-guang-yang-md 2018-05-17T19:25:54+00:00 0.51 http://waldenstroms.com/video-photos/350-paris-2004-closing-ceremonies-personal-recollections-of-my-father-part-1 2018-05-17T19:25:55+00:00 0.51 http://waldenstroms.com/video-photos/349-paris-2004-opening-ceremonies 2018-05-17T19:25:56+00:00 0.51 http://waldenstroms.com/video-photos/348-paris-2004-closing-ceremonies-personal-recollections-of-my-father-part-3 2018-05-17T19:25:56+00:00 0.51 http://waldenstroms.com/video-photos?limitstart=0 2018-05-17T19:25:57+00:00 0.51 http://waldenstroms.com/video-photos/347-paris-2004-closing-ceremonies-personal-recollections-of-my-father-part-2 2018-05-17T19:25:58+00:00 0.51 http://waldenstroms.com/video-photos/346-paris-2004-closing-ceremonies-tour-de-waldenstrom-s-part-2 2018-05-17T19:25:58+00:00 0.51 http://waldenstroms.com/video-photos/345-paris-2004-closing-ceremonies-tour-de-waldenstrom-s-part-1 2018-05-17T19:25:59+00:00 0.51 http://waldenstroms.com/video-photos/344-closing-ceremonies-of-the-2nd-international-workshop-on-wm-torch-lighting-ceremonies-part-ii 2018-05-17T19:26:00+00:00 0.51 http://waldenstroms.com/video-photos/343-closing-ceremonies-of-the-2nd-international-workshop-on-wm-torch-lighting-ceremonies-part-i 2018-05-17T19:26:01+00:00 0.51 http://waldenstroms.com/video-photos/342-iwwm-2-report-of-consensus-panel-three-2nd-intl-workshop-on-wm 2018-05-17T19:26:01+00:00 0.51 http://waldenstroms.com/video-photos/341-drs-steven-treon-and-meletios-dimopoulos-at-the-closing-ceremonies-of-the-2nd-international-workshop-on-wm 2018-05-17T19:26:02+00:00 0.51 http://waldenstroms.com/video-photos/340-iwwm-2-report-of-consensus-panel-two-2nd-intl-workshop-on-wm 2018-05-17T19:26:03+00:00 0.51 http://waldenstroms.com/video-photos/339-iwwm-2-report-of-consensus-panel-one-2nd-intl-workshop-on-wm 2018-05-17T19:26:04+00:00 0.51 http://waldenstroms.com/video-photos/338-dr-robert-kyle-addresses-the-delegates-of-the-2nd-international-workshop-on-wm-at-the-opening-ceremony 2018-05-17T19:26:04+00:00 0.51 http://waldenstroms.com/video-photos/337-dr-treon-addresses-the-delegates-at-the-opening-ceremonies-of-the-2nd-international-workshop-on-wm 2018-05-17T19:26:05+00:00 0.51 http://waldenstroms.com/video-photos/336-dr-leblond-s-presentation-at-8th-int-conference-on-malignant-lymphoma 2018-05-17T19:26:06+00:00 0.51 http://waldenstroms.com/video-photos/335-dr-bjorkholm-opens-the-8th-int-conference-on-malignant-lymphoms-in-lugano 2018-05-17T19:26:07+00:00 0.51 http://waldenstroms.com/video-photos/media-gallery?limitstart=0 2018-05-17T19:26:07+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/43-current-trials/382-ibrutinib-with-rituximab-in-adults-with-waldenstroem-s-macroglobulinemia 2018-05-17T19:26:08+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/43-current-trials/381-trial-of-ixazomib-dexamethasone-and-rituximab-in-patients-with-untreated-waldenstrom-s-macroglobulinemia 2018-05-17T19:26:09+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/44-corollary-studies/287-characteristics-of-familial-wm 2018-05-17T19:26:10+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/45-completed-trials/302-rituximab-plus-fludarabine-for-patients-with-wm 2018-05-17T19:26:10+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/45-completed-trials/301-phase-2-everolimus-rad001-in-primary-therapy-of-waldenstrom-s-macroglobulinemia 2018-05-17T19:26:11+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/45-completed-trials/300-phase-ii-study-of-velcade-ps-341-in-wm 2018-05-17T19:26:12+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/45-completed-trials/299-phase-ii-study-of-thalidomide-and-rituximab-for-patients-with-wm 2018-05-17T19:26:13+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/45-completed-trials/298-phase-ii-study-of-simvastatin-in-wm 2018-05-17T19:26:13+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/45-completed-trials/297-phase-ii-study-of-perifosine-in-patients-with-relapsed-refractory-wm 2018-05-17T19:26:14+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/45-completed-trials/296-phase-ii-study-of-imatinib-mesylate-gleevec-in-relapsed-or-refractory-wm 2018-05-17T19:26:15+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/45-completed-trials/295-phase-ii-study-of-combination-therapy-with-bortezomib-and-rituximab-in-patients-with-relapsed-refractory-waldenstrom-s-macroglobulinemia 2018-05-17T19:26:15+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/45-completed-trials/294-phase-ii-study-of-cc-5013-lenalidomide-revlimid-tm-and-rituximab-in-waldenstrom-s-macroglobulinemia 2018-05-17T19:26:16+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/45-completed-trials/293-phase-ii-clinical-trial-of-sildenafil-citrate-in-wm 2018-05-17T19:26:17+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/45-completed-trials/292-phase-ii-clinical-trial-of-rad001-in-relapsed-refractory-lymphoma 2018-05-17T19:26:18+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/45-completed-trials/291-phase-ii-clinical-trial-of-combination-therapy-with-bortezomib-dexamethasone-and-rituximab-in-patients-with-wm 2018-05-17T19:26:20+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/45-completed-trials/290-extended-rituximab-for-patients-with-wm 2018-05-17T19:26:21+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/45-completed-trials/289-campath-1h-for-patients-with-relapsed-and-refractory-wm 2018-05-17T19:26:22+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/45-completed-trials/288-an-open-label-multicenter-phase-2-study-of-single-agent-enzastaurin-hcl-in-previously-treaed-waldenstrom-s-macroglobulinemia-or-multiple-myeloma 2018-05-17T19:26:22+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/46-participating-institutions-usa/316-stanford-university-medical-center 2018-05-17T19:26:23+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/46-participating-institutions-usa/315-st-vincent-s-medical-center-ny 2018-05-17T19:26:24+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/46-participating-institutions-usa/314-rush-university 2018-05-17T19:26:25+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/46-participating-institutions-usa/313-rocky-mountain-cancer-center 2018-05-17T19:26:25+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/46-participating-institutions-usa/312-northwestern-university-medical-center 2018-05-17T19:26:26+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/46-participating-institutions-usa/311-memorial-hospital-west 2018-05-17T19:26:27+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/46-participating-institutions-usa/310-md-anderson-cancer-center 2018-05-17T19:26:27+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/46-participating-institutions-usa/309-hackensack-university-medical-center 2018-05-17T19:26:28+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/46-participating-institutions-usa/308-greenebaum-cancer-center-university-of-maryland 2018-05-17T19:26:29+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/46-participating-institutions-usa/307-fred-hutchinson-research-cancer-center 2018-05-17T19:26:29+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/46-participating-institutions-usa/306-emory-universtity-school-of-medicine 2018-05-17T19:26:30+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/46-participating-institutions-usa/305-dana-farber-cancer-institute 2018-05-17T19:26:31+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/46-participating-institutions-usa/304-columbia-university-medical-center 2018-05-17T19:26:32+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/46-participating-institutions-usa/303-baylor-sammons-cancer-center 2018-05-17T19:26:32+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/47-participating-institutions-international/325-university-of-athens-school-of-medicine 2018-05-17T19:26:33+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/47-participating-institutions-international/324-st-bartholomew-s-hospital 2018-05-17T19:26:34+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/47-participating-institutions-international/323-princess-margaret-hospital 2018-05-17T19:26:34+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/47-participating-institutions-international/322-ottawa-general-hospital 2018-05-17T19:26:35+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/47-participating-institutions-international/321-oncology-institute-of-southern-switzerland 2018-05-17T19:26:36+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/47-participating-institutions-international/320-karolinska-institutet 2018-05-17T19:26:36+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/47-participating-institutions-international/319-irccs-policlinico-san-matteo-hospital 2018-05-17T19:26:37+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/47-participating-institutions-international/318-centre-hospitalier-dr-schaffner 2018-05-17T19:26:38+00:00 0.51 http://waldenstroms.com/patients-clinic/clinical-trials/47-participating-institutions-international/317-a-o-ospedale-niguarda-ca-granda 2018-05-17T19:26:38+00:00 0.51 http://waldenstroms.com/publications/26-pub-2015/27-cxcr4-whim-like-frameshift-and-nonsense-mutations-promote-ibrutinib-resistance-but-do-not-supplant-myd88-l265p-directed-survival-signalling-in-waldenstroem-macroglobulinaemia-cells 2018-05-17T19:26:39+00:00 0.51 http://waldenstroms.com/publications/26-pub-2015/376-llf-waldenstrom-s-macroglobulinemia-facts 2018-05-17T19:26:40+00:00 0.51 http://waldenstroms.com/publications/51-pub-2018/494-myd88-mutated-and-wild-type-waldenstroems-macroglobulinemia-characterization-of-chromosome-6q-gene-losses-and-their-mutual-exclusivity-with-mutations-in-cxcr4 2018-05-17T19:26:41+00:00 0.51 http://waldenstroms.com/publications/51-pub-2018/493-extracellular-vesicle-mediated-transfer-of-constitutively-active-myd88l265p-engages-myd88supwt-and-activates-signaling 2018-05-17T19:26:41+00:00 0.51 http://waldenstroms.com/publications/51-pub-2018/492-low-levels-of-von-willebrand-markers-associate-with-high-serum-igm-levels-and-improve-with-response-to-therapy-in-patients-with-waldenstroem-macroglobulinaemia 2018-05-17T19:26:42+00:00 0.51 http://waldenstroms.com/publications/51-pub-2018/491-btk-cys481ser-drives-ibrutinib-resistance-via-erk1-2-and-protects-btk-wild-type-myd88-mutated-cells-by-a-paracrine-mechanism 2018-05-17T19:26:43+00:00 0.51 http://waldenstroms.com/publications/51-pub-2018/490-ibrutinib-withdrawal-symptoms-in-patients-with-waldenstroem-macroglobulinemia 2018-05-17T19:26:43+00:00 0.51 http://waldenstroms.com/publications/51-pub-2018/489-response-and-survival-for-primary-therapy-combination-regimens-and-maintenance-rituximab-in-waldenstroem-macroglobulinaemia 2018-05-17T19:26:44+00:00 0.51 http://waldenstroms.com/publications/51-pub-2018/488-fitting-msmart-into-the-current-clinical-management-of-waldenstroem-macroglobulinemia 2018-05-17T19:26:45+00:00 0.51 http://waldenstroms.com/publications/51-pub-2018/487-ibrutinib-discontinuation-in-waldenstroem-macroglobulinemia-etiologies-outcomes-and-igm-rebound 2018-05-17T19:26:45+00:00 0.51 http://waldenstroms.com/publications/51-pub-2018/486-myd88-wild-type-waldenstrom-macroglobulinaemia-differential-diagnosis-risk-of-histological-transformation-and-overall-survival 2018-05-17T19:26:46+00:00 0.51 http://waldenstroms.com/publications/50-pub-2017/485-what-should-be-the-goal-of-therapy-for-waldenstroem-macroglobulinemia-patients-complete-response-should-be-the-goal-of-therapy 2018-05-17T19:26:47+00:00 0.51 http://waldenstroms.com/publications/50-pub-2017/484-toward-personalized-treatment-in-waldenstroem-macroglobulinemia 2018-05-17T19:26:48+00:00 0.51 http://waldenstroms.com/publications/50-pub-2017/483-comparing-apples-to-oranges-a-commentary-on-the-mayo-study-of-myd88-significance-in-waldenstrom-s-macroglobulinemia 2018-05-17T19:26:48+00:00 0.51 http://waldenstroms.com/publications/50-pub-2017/482-myd88-wild-type-waldenstrom-macroglobulinaemia-differential-diagnosis-risk-of-histological-transformation-and-overall-survival 2018-05-17T19:26:49+00:00 0.51 http://waldenstroms.com/publications/50-pub-2017/468-novel-approaches-to-targeting-myd88-in-waldenstroem-macroglobulinemia 2018-05-17T19:26:49+00:00 0.51 http://waldenstroms.com/publications/50-pub-2017/464-the-importance-of-the-genomic-landscape-in-waldenstroem-s-macroglobulinemia-for-targeted-therapeutical-interventions 2018-05-17T19:26:50+00:00 0.51 http://waldenstroms.com/publications/50-pub-2017/463-comparative-outcomes-of-immunochemotherapy-regimens-in-waldenstrom-macroglobulinaemia 2018-05-17T19:26:51+00:00 0.51 http://waldenstroms.com/publications/50-pub-2017/458-cxcl13-levels-are-elevated-in-patients-with-waldenstrom-s-macroglobulinemia-and-are-predictive-of-major-response-to-ibrutinib 2018-05-17T19:26:51+00:00 0.51 http://waldenstroms.com/publications/50-pub-2017/448-serum-igm-level-as-predictor-of-symptomatic-hyperviscosity-in-patients-with-waldenstroem-macroglobulinaemia 2018-05-17T19:26:52+00:00 0.51 http://waldenstroms.com/publications/50-pub-2017/447-genomics-signaling-and-treatment-of-waldenstroem-macroglobulinemia 2018-05-17T19:26:53+00:00 0.51 http://waldenstroms.com/publications/50-pub-2017?start=10 2018-05-17T19:26:53+00:00 0.51 http://waldenstroms.com/publications/49-pub-2016/438-idelalisib-in-waldenstroem-macroglobulinemia-high-incidence-of-hepatotoxicity 2018-05-17T19:26:54+00:00 0.51 http://waldenstroms.com/publications/49-pub-2016/437-ibrutinib-in-waldenstroem-macroglobulinemia-latest-evidence-and-clinical-experience 2018-05-17T19:26:55+00:00 0.51 http://waldenstroms.com/publications/49-pub-2016/436-evolution-of-management-and-outcomes-in-waldenstroem-macroglobulinemia-a-population-based-analysis 2018-05-17T19:26:56+00:00 0.51 http://waldenstroms.com/publications/49-pub-2016/435-renal-disease-related-to-waldenstroem-macroglobulinaemia-incidence-pathology-and-clinical-outcomes 2018-05-17T19:26:56+00:00 0.51 http://waldenstroms.com/publications/49-pub-2016/434-treatment-recommendations-from-the-eighth-international-workshop-on-waldenstroem-s-macroglobulinemia 2018-05-17T19:26:57+00:00 0.51 http://waldenstroms.com/publications/49-pub-2016/433-histological-transformation-to-diffuse-large-b-cell-lymphoma-in-patients-with-waldenstroem-macroglobulinemia 2018-05-17T19:26:58+00:00 0.51 http://waldenstroms.com/publications/49-pub-2016/432-ibrutinib-penetrates-the-blood-brain-barrier-and-shows-efficacy-in-the-therapy-of-bing-neel-syndrome 2018-05-17T19:26:59+00:00 0.51 http://waldenstroms.com/publications/49-pub-2016/431-transcriptome-sequencing-reveals-a-profile-that-corresponds-to-genomic-variants-in-waldenstroem-macroglobulinemia 2018-05-17T19:26:59+00:00 0.51 http://waldenstroms.com/publications/49-pub-2016/430-exome-sequencing-reveals-recurrent-germ-line-variants-in-patients-with-familial-waldenstroem-macroglobulinemia 2018-05-17T19:27:00+00:00 0.51 http://waldenstroms.com/publications/49-pub-2016/406-recommendations-for-the-diagnosis-and-initial-evaluation-of-patients-with-waldenstrom-s-macroglobulinaemia-a-task-force-from-the-8th-international-workshop-on-waldenstrom-s-macroglobulinaemia 2018-05-17T19:27:01+00:00 0.51 http://waldenstroms.com/publications/49-pub-2016?start=10 2018-05-17T19:27:01+00:00 0.51 http://waldenstroms.com/publications/26-pub-2015/429-targeting-the-spleen-tyrosine-kinase-with-fostamatinib-as-a-strategy-against-waldenstroem-macroglobulinemia 2018-05-17T19:27:02+00:00 0.51 http://waldenstroms.com/publications/26-pub-2015/428-phase-i-ii-trial-of-everolimus-in-combination-with-bortezomib-and-rituximab-rvr-in-relapsed-refractory-waldenstrom-macroglobulinemia 2018-05-17T19:27:03+00:00 0.51 http://waldenstroms.com/publications/26-pub-2015/384-rituximab-intolerance-in-patients-with-waldenstrom-s-macroglobulinaemia 2018-05-17T19:27:03+00:00 0.51 http://waldenstroms.com/publications/26-pub-2015/377-myd88-mutations-and-response-to-ibrutinib-in-waldenstroem-s-macroglobulinemia 2018-05-17T19:27:04+00:00 0.51 http://waldenstroms.com/publications/26-pub-2015?start=10 2018-05-17T19:27:05+00:00 0.51 http://waldenstroms.com/publications/27-pub-2014/38-carfilzomib-rituximab-and-dexamethasone-card-treatment-offers-a-neuropathy-sparing-approach-for-treating-waldenstroem-s-macroglobulinemia 2018-05-17T19:27:05+00:00 0.51 http://waldenstroms.com/publications/27-pub-2014/37-detection-of-myd88-l265p-in-peripheral-blood-of-patients-with-waldenstrom-s-macroglobulinemia-and-igm-monoclonal-gammopathy-of-undetermined-significance 2018-05-17T19:27:06+00:00 0.51 http://waldenstroms.com/publications/27-pub-2014/36-long-term-results-of-the-phase-ii-trial-of-the-oral-mtor-inhibitor-everolimus-rad001-in-relapsed-or-refractory-waldenstrom-macroglobulinemia 2018-05-17T19:27:07+00:00 0.51 http://waldenstroms.com/publications/27-pub-2014/35-myd88-independent-growth-and-survival-effects-of-sp1-transactivation-in-waldenstroem-macroglobulinemia 2018-05-17T19:27:07+00:00 0.51 http://waldenstroms.com/publications/27-pub-2014/34-somatic-mutations-in-myd88-and-cxcr4-are-determinants-of-clinical-presentation-and-overall-survival-in-waldenstrom-s-macroglobulinemia 2018-05-17T19:27:08+00:00 0.51 http://waldenstroms.com/publications/27-pub-2014/33-survival-trends-in-waldenstrom-macroglobulinemia-an-analysis-of-the-surveillance-epidemiology-and-end-results-database 2018-05-17T19:27:09+00:00 0.51 http://waldenstroms.com/publications/27-pub-2014/32-the-genomic-landscape-of-waldenstrom-macroglobulinemia-is-characterized-by-highly-recurring-myd88-and-whim-like-cxcr4-mutations-and-small-somatic-deletions-associated-with-b-cell-lymphomagenesis 2018-05-17T19:27:09+00:00 0.51 http://waldenstroms.com/publications/27-pub-2014/31-transcriptional-repression-of-plasma-cell-differentiation-is-orchestrated-by-aberrant-over-expression-of-the-ets-factor-spib-in-waldenstroem-macroglobulinaemia 2018-05-17T19:27:10+00:00 0.51 http://waldenstroms.com/publications/27-pub-2014/30-treatment-recommendations-for-patients-with-waldenstroem-macroglobulinemia-wm-and-related-disorders-iwwm-7-consensus 2018-05-17T19:27:11+00:00 0.51 http://waldenstroms.com/publications/27-pub-2014/29-waldenstrom-macroglobulinemia 2018-05-17T19:27:12+00:00 0.51 http://waldenstroms.com/publications/27-pub-2014?start=10 2018-05-17T19:27:12+00:00 0.51 http://waldenstroms.com/publications/28-pub-2013/48-a-mutation-in-myd88-l265p-supports-the-survival-of-lymphoplasmacytic-cells-by-activation-of-bruton-s-tyrosine-kinase-in-waldenstrom-s-macroglobulinemia 2018-05-17T19:27:13+00:00 0.51 http://waldenstroms.com/publications/28-pub-2013/47-a-new-era-for-waldenstrom-macroglobulinemia-myd88-l265p 2018-05-17T19:27:14+00:00 0.51 http://waldenstroms.com/publications/28-pub-2013/46-myd88-l265p-in-waldenstrom-s-macroglobulinemia-igm-monoclonal-gammopathy-and-other-b-cell-lymphoproliferative-disorders-using-conventional-and-quantitative-allele-specific-pcr 2018-05-17T19:27:14+00:00 0.51 http://waldenstroms.com/publications/28-pub-2013/45-patients-with-waldenstroem-macroglobulinemia-commonly-present-with-iron-deficiency-and-those-with-severely-depressed-transferrin-saturation-levels-show-response-to-parenteral-iron-administration 2018-05-17T19:27:15+00:00 0.51 http://waldenstroms.com/publications/28-pub-2013/44-proceedings-from-the-7th-international-workshop-on-waldenstrom-s-macroglobulinemia-iwwm-7 2018-05-17T19:27:15+00:00 0.51 http://waldenstroms.com/publications/28-pub-2013/43-proteasome-inhibitors-in-waldenstroem-macroglobulinemia 2018-05-17T19:27:16+00:00 0.51 http://waldenstroms.com/publications/28-pub-2013/42-results-of-the-phase-ii-trial-of-single-agent-histone-deacetylase-inhibitor-panobinostat-in-patients-with-relapsed-refractory-waldenstrom-macroglobulinemia 2018-05-17T19:27:17+00:00 0.51 http://waldenstroms.com/publications/28-pub-2013/41-the-epidemiology-of-herpes-zoster-in-patients-with-newly-diagnosed-cancer 2018-05-17T19:27:17+00:00 0.51 http://waldenstroms.com/publications/28-pub-2013/40-the-genomic-landscape-of-waldenstrom-s-macroglobulinemia-is-characterized-by-highly-recurring-myd88-and-whim-like-mutations-and-small-somatic-deletions-associated-with-b-cell-lymphomagenesis 2018-05-17T19:27:18+00:00 0.51 http://waldenstroms.com/publications/28-pub-2013/39-waldenstrom-s-macroglobulinaemia-an-indolent-b-cell-lymphoma-with-distinct-molecular-and-clinical-features 2018-05-17T19:27:19+00:00 0.51 http://waldenstroms.com/publications/29-pub-2012/61-a-multicenter-phase-ii-study-of-single-agent-enzastaurin-in-previously-treated-waldenstrom-macroglobulinemia 2018-05-17T19:27:19+00:00 0.51 http://waldenstroms.com/publications/29-pub-2012/60-bruton-tyrosine-kinase-inhibition-is-a-novel-therapeutic-strategy-targeting-tumor-in-the-bone-marrow-microenvironment-in-multiple-myeloma 2018-05-17T19:27:20+00:00 0.51 http://waldenstroms.com/publications/29-pub-2012/59-challenges-with-serum-protein-electrophoresis-in-assessing-progression-and-clinical-response-in-patients-with-waldenstroem-macroglobulinemia 2018-05-17T19:27:21+00:00 0.51 http://waldenstroms.com/publications/29-pub-2012/58-comparative-response-assessment-by-serum-immunoglobulin-m-m-protein-and-total-serum-immunoglobulin-m-after-treatment-of-patients-with-waldenstroem-macroglobulinemia 2018-05-17T19:27:21+00:00 0.51 http://waldenstroms.com/publications/29-pub-2012/57-familial-disease-predisposition-impacts-treatment-outcome-in-patients-with-waldenstroem-macroglobulinemia 2018-05-17T19:27:22+00:00 0.51 http://waldenstroms.com/publications/29-pub-2012/56-family-history-of-non-hematologic-cancers-among-waldenstrom-macroglobulinemia-patients-a-preliminary-study 2018-05-17T19:27:23+00:00 0.51 http://waldenstroms.com/publications/29-pub-2012/55-mechanisms-of-activity-of-the-torc1-inhibitor-everolimus-in-waldenstrom-macroglobulinemia 2018-05-17T19:27:24+00:00 0.51 http://waldenstroms.com/publications/29-pub-2012/54-microrna-aberrations-in-waldenstroem-macroglobulinemia 2018-05-17T19:27:24+00:00 0.51 http://waldenstroms.com/publications/29-pub-2012/53-molecular-and-cellular-effects-of-nedd8-activating-enzyme-inhibition-in-myeloma 2018-05-17T19:27:25+00:00 0.51 http://waldenstroms.com/publications/29-pub-2012/52-multiple-myeloma-version-1-2013 2018-05-17T19:27:26+00:00 0.51 http://waldenstroms.com/publications/29-pub-2012?start=10 2018-05-17T19:27:26+00:00 0.51 http://waldenstroms.com/publications/30-pub-2011/75-associated-malignancies-in-patients-with-waldenstrom-s-macroglobulinemia-and-their-kin 2018-05-17T19:27:27+00:00 0.51 http://waldenstroms.com/publications/30-pub-2011/74-attainment-of-complete-very-good-partial-response-following-rituximab-based-therapy-is-an-important-determinant-to-progression-free-survival-and-is-impacted-by-polymorphisms-in-fcgr3a-in-waldenstrom-s-macroglobulinemia 2018-05-17T19:27:28+00:00 0.51 http://waldenstroms.com/publications/30-pub-2011/73-bendamustine-therapy-in-patients-with-relapsed-or-refractory-waldenstrom-s-macroglobulinemia 2018-05-17T19:27:28+00:00 0.51 http://waldenstroms.com/publications/30-pub-2011/72-carfilzomib-dependent-selective-inhibition-of-the-chymotrypsin-like-activity-of-the-proteasome-leads-to-antitumor-activity-in-waldenstrom-s-macroglobulinemia 2018-05-17T19:27:29+00:00 0.51 http://waldenstroms.com/publications/30-pub-2011/71-hepcidin-is-produced-by-lymphoplasmacytic-cells-and-is-associated-with-anemia-in-waldenstrom-s-macroglobulinemia 2018-05-17T19:27:30+00:00 0.51 http://waldenstroms.com/publications/30-pub-2011/70-histone-deacetylase-inhibitors-demonstrate-significant-preclinical-activity-as-single-agents-and-in-combination-with-bortezomib-in-waldenstrom-s-macroglobulinemia 2018-05-17T19:27:30+00:00 0.51 http://waldenstroms.com/publications/30-pub-2011/68-hyperphosphorylated-paratarg-7-a-new-molecularly-defined-risk-factor-for-monoclonal-gammopathy-of-undetermined-significance-of-the-igm-type-and-waldenstroem-macroglobulinemia 2018-05-17T19:27:31+00:00 0.51 http://waldenstroms.com/publications/30-pub-2011/67-long-term-follow-up-of-symptomatic-patients-with-lymphoplasmacytic-lymphoma-waldenstrom-s-macroglobulinemia-treated-with-the-anti-cd52-monoclonal-antibody-alemtuzumab 2018-05-17T19:27:32+00:00 0.51 http://waldenstroms.com/publications/30-pub-2011/66-maintenance-rituximab-is-associated-with-improved-clinical-outcome-in-rituximab-na-ve-patients-with-waldenstrom-macroglobulinaemia-who-respond-to-a-rituximab-containing-regimen 2018-05-17T19:27:32+00:00 0.51 http://waldenstroms.com/publications/30-pub-2011?start=10 2018-05-17T19:27:33+00:00 0.51 http://waldenstroms.com/publications/31-pub-2010/82-bortezomib-as-a-treatment-option-in-patients-with-waldenstrom-macroglobulinemia 2018-05-17T19:27:34+00:00 0.51 http://waldenstroms.com/publications/31-pub-2010/81-elevated-il-17-produced-by-th17-cells-promotes-myeloma-cell-growth-and-inhibits-immune-function-in-multiple-myeloma 2018-05-17T19:27:34+00:00 0.51 http://waldenstroms.com/publications/31-pub-2010/80-fcy-receptor-predictive-genomic-testing-and-the-treatment-of-indolent-non-hodgkin-lymphoma 2018-05-17T19:27:35+00:00 0.51 http://waldenstroms.com/publications/31-pub-2010/79-iga-and-igg-hypogammaglobulinemia-in-waldenstroem-s-macroglobulinemia 2018-05-17T19:27:35+00:00 0.51 http://waldenstroms.com/publications/31-pub-2010/78-phase-ii-trial-of-the-oral-mammalian-target-of-rapamycin-inhibitor-everolimus-in-relapsed-or-refractory-waldenstrom-macroglobulinemia 2018-05-17T19:27:36+00:00 0.51 http://waldenstroms.com/publications/31-pub-2010/77-phase-ii-trial-of-weekly-bortezomib-in-combination-with-rituximab-in-relapsed-or-relapsed-and-refractory-waldenstrom-macroglobulinemia 2018-05-17T19:27:37+00:00 0.51 http://waldenstroms.com/publications/31-pub-2010/76-phase-ii-trial-of-weekly-bortezomib-in-combination-with-rituximab-in-untreated-patients-with-waldenstroem-macroglobulinemia 2018-05-17T19:27:37+00:00 0.51 http://waldenstroms.com/publications/32-pub-2009/91-advances-in-the-biology-and-treatment-of-waldenstroem-s-macroglobulinemia-a-report-from-the-5th-international-workshop-on-waldenstroem-s-macroglobulinemia-stockholm-sweden 2018-05-17T19:27:38+00:00 0.51 http://waldenstroms.com/publications/32-pub-2009/90-comparative-outcomes-following-cp-r-cvp-r-and-chop-r-in-waldenstroem-s-macroglobulinemia 2018-05-17T19:27:39+00:00 0.51 http://waldenstroms.com/publications/32-pub-2009/89-expression-of-regulatory-genes-for-lymphoplasmacytic-cell-differentiation-in-waldenstrom-macroglobulinemia 2018-05-17T19:27:39+00:00 0.51 http://waldenstroms.com/publications/32-pub-2009/88-how-i-treat-waldenstrom-s-macroglobulinemia 2018-05-17T19:27:40+00:00 0.51 http://waldenstroms.com/publications/32-pub-2009/87-iga-and-igg-hypogammaglobulinemia-in-waldenstroem-s-macroglobulinemia 2018-05-17T19:27:41+00:00 0.51 http://waldenstroms.com/publications/32-pub-2009/86-international-prognostic-scoring-system-for-waldenstrom-s-macroglobulinemia 2018-05-17T19:27:41+00:00 0.51 http://waldenstroms.com/publications/32-pub-2009/85-lenalidomide-and-rituximab-in-waldenstrom-s-macroglobulinemia 2018-05-17T19:27:42+00:00 0.51 http://waldenstroms.com/publications/32-pub-2009/84-primary-therapy-of-waldenstroem-macroglobulinemia-with-bortezomib-dexamethasone-and-rituximab-wmctg-clinical-trial-05-180 2018-05-17T19:27:42+00:00 0.51 http://waldenstroms.com/publications/32-pub-2009/83-soluble-cd27-is-a-faithful-marker-of-disease-burden-and-is-unaffected-by-the-rituximab-induced-igm-flare-as-well-as-by-plasmapheresis-in-patients-with-waldenstroem-s-macroglobulinemia 2018-05-17T19:27:43+00:00 0.51 http://waldenstroms.com/publications/33-pub-2008/107-advances-in-the-treatment-of-monoclonal-gammopaties-the-emerging-role-of-targeted-therapy-in-plasma-cell-dyscrasias 2018-05-17T19:27:44+00:00 0.51 http://waldenstroms.com/publications/33-pub-2008/106-cd27-cd70-interactions-in-the-pathogenesis-of-waldenstrom-s-macroglobulinemia 2018-05-17T19:27:44+00:00 0.51 http://waldenstroms.com/publications/33-pub-2008/105-clinical-relevance-of-soluble-hla-class-i-molecules-in-waldenstrom-s-macroglobulinemia 2018-05-17T19:27:45+00:00 0.51 http://waldenstroms.com/publications/33-pub-2008/104-dual-targeting-of-the-proteasome-regulates-survival-and-homing-in-waldenstrom-macroglobulinemia 2018-05-17T19:27:46+00:00 0.51 http://waldenstroms.com/publications/33-pub-2008/103-effect-of-plasmapheresis-on-hyperviscosity-related-retinopathy-and-retinal-hemodynamics-in-patients-with-waldenstrom-s-macroglobulinemia 2018-05-17T19:27:46+00:00 0.51 http://waldenstroms.com/publications/33-pub-2008/102-endoplasmic-reticulum-stress-is-a-target-for-therapy-in-waldenstrom-macroglobulinemia 2018-05-17T19:27:47+00:00 0.51 http://waldenstroms.com/publications/33-pub-2008/101-increased-incidence-of-transformation-and-myelodysplasia-acute-leukemia-in-patients-with-waldenstroem-macroglobulinemia-treated-with-nucleoside-analogs 2018-05-17T19:27:48+00:00 0.51 http://waldenstroms.com/publications/33-pub-2008/99-inherited-and-acquired-variations-in-the-hyaluronan-synthase-1-has1-gene-may-contribute-to-disease-progression-in-multiple-myeloma-and-waldenstrom-s-macroglobulinemia 2018-05-17T19:27:48+00:00 0.51 http://waldenstroms.com/publications/33-pub-2008/98-long-term-outcomes-to-fludarabine-and-rituximab-in-waldenstrom-macroglobulinemia 2018-05-17T19:27:49+00:00 0.51 http://waldenstroms.com/publications/33-pub-2008/97-resveratrol-exerts-antiproliferative-activity-and-induces-apoptosis-in-waldenstroem-s-macroglobulinemia 2018-05-17T19:27:50+00:00 0.51 http://waldenstroms.com/publications/33-pub-2008?start=10 2018-05-17T19:27:50+00:00 0.51 http://waldenstroms.com/publications/34-pub-2007/117-establishment-of-bcwm-1-cell-line-for-waldenstroem-s-macroglobulinemia-with-productive-in-vivo-engraftment-in-scid-hu-mice 2018-05-17T19:27:51+00:00 0.51 http://waldenstroms.com/publications/34-pub-2007/116-genetic-linkage-of-fc-gamma-riia-and-fc-gamma-riiia-and-implications-for-their-use-in-predicting-clinical-responses-to-cd20-directed-monoclonal-antibody-therapy 2018-05-17T19:27:52+00:00 0.51 http://waldenstroms.com/publications/34-pub-2007/115-hepatitis-c-viral-infection-is-not-associated-with-waldenstroem-s-macroglobulinemia 2018-05-17T19:27:52+00:00 0.51 http://waldenstroms.com/publications/34-pub-2007/114-increased-natural-killer-cell-expression-of-cd16-augmented-binding-and-adcc-activity-to-rituximab-among-individuals-expressing-the-fc-gamma-riiia-158-v-v-and-v-f-polymorphism 2018-05-17T19:27:53+00:00 0.51 http://waldenstroms.com/publications/34-pub-2007/113-molecular-characterization-of-waldenstrom-s-macroglobulinemia-reveals-frequent-occurrence-of-two-b-cell-clones-having-distinct-igh-vdj-sequences 2018-05-17T19:27:54+00:00 0.51 http://waldenstroms.com/publications/34-pub-2007/112-multicenter-clinical-trial-of-bortezomib-in-relapsed-refractory-waldenstrom-s-macroglobulinemia-results-of-wmctg-trial-03-248 2018-05-17T19:27:54+00:00 0.51 http://waldenstroms.com/publications/34-pub-2007/111-novel-agents-in-the-treatment-of-waldenstroem-s-macroglobulinemia 2018-05-17T19:27:55+00:00 0.51 http://waldenstroms.com/publications/34-pub-2007/110-protein-kinase-c-inhibitor-enzastaurin-induces-in-vitro-and-in-vivo-antitumor-activity-in-waldenstrom-macroglobulinemia 2018-05-17T19:27:56+00:00 0.51 http://waldenstroms.com/publications/34-pub-2007/109-proteomic-analysis-of-waldenstrom-macroglobulinemia 2018-05-17T19:27:56+00:00 0.51 http://waldenstroms.com/publications/34-pub-2007/108-the-akt-pathway-regulates-survival-and-homing-in-waldenstrom-macroglobulinemia 2018-05-17T19:27:57+00:00 0.51 http://waldenstroms.com/publications/35-pub-2006/126-cd52-is-expressed-on-human-mast-cells-and-is-a-potential-therapeutic-target-in-waldenstrom-s-macroglobulinemia-and-mast-cell-disorders 2018-05-17T19:27:57+00:00 0.51 http://waldenstroms.com/publications/35-pub-2006/125-characterization-of-familial-waldenstrom-s-macroglobulinemia 2018-05-17T19:27:58+00:00 0.51 http://waldenstroms.com/publications/35-pub-2006/124-heterogeneous-cd52-expression-among-hematologic-neoplasms-implications-for-the-use-of-alemtuzumab-campath-1h 2018-05-17T19:28:00+00:00 0.51 http://waldenstroms.com/publications/35-pub-2006/123-hyperviscosity-related-retinopathy-in-waldenstrom-macroglobulinemia 2018-05-17T19:28:01+00:00 0.51 http://waldenstroms.com/publications/35-pub-2006/122-infectious-complications-associated-with-alemtuzumab-use-for-lymphoproliferative-disorders 2018-05-17T19:28:02+00:00 0.51 http://waldenstroms.com/publications/35-pub-2006/121-mast-cells-in-waldenstrom-s-macroglobulinemia-support-lymphoplasmacytic-cell-growth-through-cd154-cd40-signaling 2018-05-17T19:28:02+00:00 0.51 http://waldenstroms.com/publications/35-pub-2006/120-specific-killing-of-multiple-myeloma-cells-by-epigallocatechin-3-gallate-extracted-from-green-tea-biologic-activity-and-therapeutic-implications 2018-05-17T19:28:03+00:00 0.51 http://waldenstroms.com/publications/35-pub-2006/119-update-on-recommendations-for-assessing-response-from-the-third-international-workshop-on-waldenstrom-s-macroglobulinemia 2018-05-17T19:28:04+00:00 0.51 http://waldenstroms.com/publications/35-pub-2006/118-update-on-treatment-recommendations-from-the-third-international-workshop-on-waldenstrom-s-macroglobulinemia 2018-05-17T19:28:04+00:00 0.51 http://waldenstroms.com/publications/36-pub-2005/135-a-scid-hu-in-vivo-model-of-human-waldenstroem-macroglobulinemia 2018-05-17T19:28:05+00:00 0.51 http://waldenstroms.com/publications/36-pub-2005/134-cd5-cd10-and-cd23-expression-in-waldenstrom-s-macroglobulinemia 2018-05-17T19:28:06+00:00 0.51 http://waldenstroms.com/publications/36-pub-2005/133-chop-plus-rituximab-therapy-in-waldenstrom-s-macroglobulinemia 2018-05-17T19:28:06+00:00 0.51 http://waldenstroms.com/publications/36-pub-2005/132-diagnosis-and-management-of-waldenstrom-s-macroglobulinemia 2018-05-17T19:28:07+00:00 0.51 http://waldenstroms.com/publications/36-pub-2005/131-extended-rituximab-therapy-in-waldenstroem-s-macroglobulinemia 2018-05-17T19:28:08+00:00 0.51 http://waldenstroms.com/publications/36-pub-2005/130-immunomodulatory-drug-lenalidomide-cc-5013-imid3-augments-anti-cd40-sgn-40-induced-cytotoxicity-in-human-multiple-myeloma-clinical-implications 2018-05-17T19:28:08+00:00 0.51 http://waldenstroms.com/publications/36-pub-2005/129-molecular-mechanisms-whereby-immunomodulatory-drugs-activate-natural-killer-cells-clinical-application 2018-05-17T19:28:09+00:00 0.51 http://waldenstroms.com/publications/36-pub-2005/128-polymorphisms-in-fcgammariiia-cd16-receptor-expression-are-associated-with-clinical-response-to-rituximab-in-waldenstroem-s-macroglobulinemia 2018-05-17T19:28:10+00:00 0.51 http://waldenstroms.com/publications/36-pub-2005/127-potential-impact-of-a-single-nucleotide-polymorphism-in-the-hyaluronan-synthase-1-gene-in-waldenstrom-s-macroglobulinemia 2018-05-17T19:28:10+00:00 0.51 http://waldenstroms.com/publications/37-pub-2004/141-amyloidosis-and-waldenstroem-s-macroglobulinemia 2018-05-17T19:28:11+00:00 0.51 http://waldenstroms.com/publications/37-pub-2004/140-clinical-responses-to-sildenafil-in-waldenstrom-s-macroglobulinemia 2018-05-17T19:28:12+00:00 0.51 http://waldenstroms.com/publications/37-pub-2004/139-clonotypic-igm-v-d-j-sequence-analysis-in-waldenstrom-macroglobulinemia-suggests-an-unusual-b-cell-origin-and-an-expansion-of-polyclonal-b-cells-in-peripheral-blood 2018-05-17T19:28:12+00:00 0.51 http://waldenstroms.com/publications/37-pub-2004/138-mechanisms-by-which-sgn-40-a-humanized-anti-cd40-antibody-induces-cytotoxicity-in-human-multiple-myeloma-cells-clinical-implications 2018-05-17T19:28:13+00:00 0.51 http://waldenstroms.com/publications/37-pub-2004/137-paradoxical-increases-in-serum-igm-and-viscosity-levels-following-rituximab-in-waldenstrom-s-macroglobulinemia 2018-05-17T19:28:14+00:00 0.51 http://waldenstroms.com/publications/37-pub-2004/136-tumour-cell-dendritic-cell-fusions-as-a-vaccination-strategy-for-multiple-myeloma 2018-05-17T19:28:14+00:00 0.51 http://waldenstroms.com/publications/38-pub-2003/153-cd40-induces-human-multiple-myeloma-cell-migration-via-phosphatidylinositol-3-kinase-akt-nf-kappa-b-signaling 2018-05-17T19:28:15+00:00 0.51 http://waldenstroms.com/publications/38-pub-2003/152-clinicopathological-definition-of-waldenstrom-s-macroglobulinemia-consensus-panel-recommendations-from-the-second-international-workshop-on-waldenstrom-s-macroglobulinemia 2018-05-17T19:28:16+00:00 0.51 http://waldenstroms.com/publications/38-pub-2003/151-defining-waldenstroem-s-macroglobulinemia 2018-05-17T19:28:16+00:00 0.51 http://waldenstroms.com/publications/38-pub-2003/150-expression-of-serotherapy-target-antigens-in-waldenstrom-s-macroglobulinemia-therapeutic-applications-and-considerations 2018-05-17T19:28:17+00:00 0.51 http://waldenstroms.com/publications/38-pub-2003/149-fluorescence-imaging-of-multiple-myeloma-cells-in-a-clinically-relevant-scid-nod-in-vivo-model-biologic-and-clinical-implications 2018-05-17T19:28:18+00:00 0.51 http://waldenstroms.com/publications/38-pub-2003/148-novel-biologically-based-therapies-for-waldenstrom-s-macroglobulinemia 2018-05-17T19:28:19+00:00 0.51 http://waldenstroms.com/publications/38-pub-2003/147-prognostic-markers-and-criteria-to-initiate-therapy-in-waldenstrom-s-macroglobulinemia-consensus-panel-recommendations-from-the-second-international-workshop-on-waldenstrom-s-macroglobulinemia 2018-05-17T19:28:19+00:00 0.51 http://waldenstroms.com/publications/38-pub-2003/146-proteomic-analyses-in-waldenstrom-s-macroglobulinemia-and-other-plasma-cell-dyscrasias 2018-05-17T19:28:20+00:00 0.51 http://waldenstroms.com/publications/38-pub-2003/145-recombinant-humanized-anti-cd40-monoclonal-antibody-triggers-autologous-antibody-dependent-cell-mediated-cytotoxicity-against-multiple-myeloma-cells 2018-05-17T19:28:20+00:00 0.51 http://waldenstroms.com/publications/38-pub-2003/144-the-malignant-clone-in-waldenstrom-s-macroglobulinemia 2018-05-17T19:28:21+00:00 0.51 http://waldenstroms.com/publications/38-pub-2003?start=10 2018-05-17T19:28:22+00:00 0.51 http://waldenstroms.com/publications/39-pub-2001-2002/165-activation-of-nf-kappab-and-upregulation-of-intracellular-anti-apoptotic-proteins-via-the-igf-1-akt-signaling-in-human-multiple-myeloma-cells-therapeutic-implications 2018-05-17T19:28:22+00:00 0.51 http://waldenstroms.com/publications/39-pub-2001-2002/164-adherence-of-multiple-myeloma-cells-to-bone-marrow-stromal-cells-upregulates-vascular-endothelial-growth-factor-secretion-therapeutic-applications 2018-05-17T19:28:23+00:00 0.51 http://waldenstroms.com/publications/39-pub-2001-2002/163-apoptotic-signaling-induced-by-immunomodulatory-thalidomide-analogs-in-human-multiple-myeloma-cells-therapeutic-implications 2018-05-17T19:28:24+00:00 0.51 http://waldenstroms.com/publications/39-pub-2001-2002/162-biologic-sequelae-of-nuclear-factor-kappab-blockade-in-multiple-myeloma-therapeutic-applications 2018-05-17T19:28:24+00:00 0.51 http://waldenstroms.com/publications/39-pub-2001-2002/161-cd20-directed-antibody-mediated-immunotherapy-induces-responses-and-facilitates-hematologic-recovery-in-patients-with-waldenstrom-s-macroglobulinemia 2018-05-17T19:28:25+00:00 0.51 http://waldenstroms.com/publications/39-pub-2001-2002/160-cd20-directed-serotherapy-in-patients-with-multiple-myeloma-biologic-considerations-and-therapeutic-applications 2018-05-17T19:28:26+00:00 0.51